Fulgent Genetics (FLGT) Cash from Operations (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Cash from Operations data on file, last reported at 7097000.0 in Q1 2026.

• Quarterly Cash from Operations rose 260.17% year-over-year to 7097000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 90110000.0 (down 1062.41% YoY) and the FY2025 annual result came in at 101638000.0, down 582.61% from the prior year.
• Cash from Operations advanced to 7097000.0 in Q1 2026 per FLGT's latest filing, from 78143000.0 in the prior quarter.
• The five-year high for Cash from Operations was 188411000.0 in Q1 2022, with the low at 78143000.0 in Q4 2025.
• Average Cash from Operations over 5 years is 12178941.18, with a median of 9737000.0 recorded in 2023.
• Year-over-year, Cash from Operations plunged 804.11% in 2025 and surged 260.17% in 2026.
• Fulgent Genetics' Cash from Operations stood at 33207000.0 in 2022, then sank by 55.03% to 14933000.0 in 2023, then surged by 67.53% to 25018000.0 in 2024, then sank by 412.35% to 78143000.0 in 2025, then surged by 109.08% to 7097000.0 in 2026.
• Business Quant data shows FLGT's Cash from Operations at 7097000.0 in Q1 2026, 78143000.0 in Q4 2025, and 11107000.0 in Q3 2025.